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a b s t r a c t 
A 15-year-old female with primary amenorrhea, obesity, and insulin resistance, was admit- 
ted for further examination due to large pelvic masses found during a transabdominal ul- 
trasound, which was performed while assessing the amenorrhea. The magnetic resonance 
imaging showed bilateral, multifocal fibrosing tumors, originating from both ovaries. A la- 
parotomy was performed, during which the right ovary masses were enucleated and the 
left adnexectomy was performed. A histological examination of the tissue material revealed 
bilateral ovarian fibromas with calcification and ossification. The genetic examination con- 
firmed the diagnosis of Gorlin syndrome. The patient recovered well, and on the first follow- 
up 1 month after surgery, already experienced her first spontaneous menstrual bleeding. 
© 2021 The Authors. Published by Elsevier Inc. on behalf of University of Washington. 
This is an open access article under the CC BY-NC-ND license 
















Adnexal tumors are uncommon in children. Among them,
10%-20% of ovarian tumors are malignant [1–3] . Ovarian
masses are mostly cystic, and solid tumors are very rare. Fi-
broma is the most common solid ovarian tumor [4] , often seen
in adults but rarely in children [5] . While radiological investi-
gation, tumor markers and clinical manifestations can point
in the right direction, a histological examination following✩ Competing Interests: The authors declare that they have no known 
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[ 1 ,4 ]. When an ovarian mass presents in a girl or an adolescent,
the highest priority issue is histological pattern and effect on
fertility [ 2 ,6 ]. Given this consideration as well as the rarity of
malignant diseases, avoiding excessively aggressive surgery is
important [2] . 
This report demonstrates a case of large, bilateral ovar-
ian fibromas in an adolescent, associated with a genetic syn-
drome called Gorlin syndrome. competing financial interests or personal relationships that could 
niversity of Washington. This is an open access article under the 
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Fig. 1 – MRI images of bilateral fibroma-type masses in both 
ovaries: (a) several separate masses (arrows) in the right 
ovary (the border of the ovary is well discernible), (b) 
massive complex solid tumor that occupies most of the 
pelvis; given the absence of the left ovary and the similarity 
of the masses to the formations found in the right ovary, 
suspicions were raised that the whole conglomerate 























































































A 15-year-old female was admitted for further investigations
due to an ultrasonographically detected abnormal mass in
the small pelvis. The patient presented with primary amen-
orrhea, obesity, and insulin resistance. She had a history of a
hydroureteronephrotic transformation in the left kidney, cor-
rected surgically with a ureterocystoneostomy at the age of 1.
Upon admission, the patient was obese, with height of
1.70 m ( + 1 SD) and weight of 83.5 kg ( + 3 SD). The patient’s
body-mass index (BMI) was 28.9 kg/m 2 , placing the BMI-for-
age at the 96th percentile for girls aged 15 years and 3 months.
The patient had normal external genitalia; acne, hirsutism or
other signs of virilization were not noted. Her secondary sex-
ual characteristics corresponded to the Tanner scale IV. 
The patient underwent pelvic magnetic resonance imaging
(MRI). The MRI revealed 5 masses arising from the right ovary;
the size of the largest mass was 3.5 cm × 2.5 cm × 2.1 cm. Nor-
mal follicles in the right ovary were not detected on magnetic
resonance (MR) images. The left ovary was presumed to be a
source of several large fusing masses, forming a conglomerate
of size 16 cm × 11 cm × 7.3 cm ( Fig. 1 ). All the lesions were iso-
and hypointense to normal muscle in T1-weighted images,
and they showed low signal intensity in T2-weighted images.
In the T1 gadolinium enhanced series, the tumors showed in-
tensive enhancement with several avascular regions within
the largest mass. It was concluded that the pelvic masses were
fibrotic in nature, most likely, a bilateral sclerosing multifocal
ovarian tumor—a rare stromal tumor presenting with bilat-
eral solid masses [7] . Further abdominal MRI and native chest
CT scans excluded tumor dissemination. The patient was re-
ferred to skeletal scintigraphy, which detected uptake of the
preparation in the pelvic masses; no evidence of bone metas-
tases was found. 
The patient had a normal female karyotype of 46, XX. The
sex hormone levels were appropriate for puberty. Also, thethyroid stimulating hormone (TSH) level was in the reference
range. Only the prolactin level was insignificantly raised, be-
ing 327.9 μU/mL over the reference range of < 300 μU/mL. Sev-
eral tumor markers were tested: levels of Cancer Antigen 125
(CA-125), Carcinoembryonic Antigen (CEA), Alpha Fetoprotein
(AFP) and free beta-Chorionic Gonadotropin (beta-HCG) were
normal. The Neuron-specific Enolase (NSE) level was faintly
elevated (17.4 μg/L), exceeding the reference range of < 17.00
μg/L. Additionally, the alkaline phosphatase level (178 U/L) ex-
ceeded the reference range of 50-117 U/L. In general, there was
no evidence that the tumor was hormonally active. 
During the laparotomy, normal ovarian tissue on the left
side was not visually detected, as it was fully replaced by the
tumor tissue consisting of several fused masses, the largest
one being around 10 cm in diameter ( Fig. 2 ). This conglomerate
had formed adhesions with adjacent structures—the uterus
and colon. The left adnexectomy was performed. The right
ovary was enlarged, and 5 tumor lesions were palpated rang-
ing from 15 mm till 35 mm in diameter. In order to spare
normal ovarian tissue, all the masses from the right ovary
were enucleated. Additional biopsy samples were taken from
the omentum and peritoneum. The size of the uterus corre-
sponded to the prepubertal age, but with no apparent patho-
logical findings. The histological examination of the surgical
sample revealed multiple calcified and ossified ovarian fibro-
mas ( Fig. 3 ), with no evidence of malignancy found in the tis-
sue samples. Due to the relationship of the ovarian fibroma
with genetic syndromes [8] including nevoid basal cell carci-
noma syndrome (Gorlin syndrome) [ 5 ,9–11 ], the patient was
referred to genetic tests which confirmed this syndrome. 
During the follow-up, the gynecological ultrasound showed
an adequate blood flow, normal structure, and size of the right
ovary, with several small follicles. The size of the uterus was
only slightly increased since the surgery, and the patient had
started menstruating on the 27th postoperative day. At the 6-
month follow-up visit the patient had no complaints, and her
uterus had increased in size reaching normal adult range. Her
period was regular: lasting 27-29 days with moderate bleed-
ing for 5 days. She had developed a small hemorrhagic cyst in
the right ovary, confirming the functionality of the organ. Re-
peated testing of sex steroids showed values corresponding to
normal ovarian function. 
Discussion 
Ovarian fibromas are generally uncommon, making up only
1%-4.7% of total ovarian tumors [9] . Fibromas occur at all ages
being most frequent in late reproductive ages; however, in pa-
tients under 30 years of age, fibroids occur in less than 10%
of cases [12] . In children, fibroma-type masses are exception-
ally rare, and literary data suggest that thecoma-fibroma type
tumors represent less than 2% of all pediatric ovarian masses
[ 3 ,13 ]. In 90% of cases, ovarian fibromas are unilateral [5] . They
are mostly benign, although cases of transformation to malig-
nant disease have been described [ 4 ,9 ,14 ]. Although ovarian fi-
bromas are mostly seen in peri- and postmenopausal women
with the median age of 45 years [4] , in young patients sex cord
stromal tumors have been occasionally reported (median age
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Fig. 2 – Gross pathology of the ovarian fibromas: surgical specimens; (a) the massive complex solid tumor in the left ovary, 
(b) the diameter of the largest mass is around 10 cm several separate masses in the right ovary. 
Fig. 3 – Histological pattern present in the masses: ovarian 
fibroma with multiple calcification foci (arrow) 











































13 years). According to literature, the fibroma-thecoma tumor
group is often associated with genetic syndromes [8] . Bilateral
fibromas are in turn associated with Gorlin syndrome [3] —
nevoid basal cell carcinoma syndrome. 
Literature suggests, that in pediatric patients with diag-
nosed bilateral, calcified ovarian fibromas, Gorlin syndrome
must be considered [ 3 ,9 ,15 ]. Gorlin syndrome is a rare genetic
syndrome of multiple basal cell carcinomas related to other
abnormalities, such as jaw cysts, skeletal anomalies, medul-
loblastomas, and ovarian fibromas [15] . Seventy-five percent
of calcified bilateral ovarian fibromas are associated with Gor-lin syndrome [9] . In turn, it is estimated that fibromas will de-
velop in 2%-25% of females with Gorlin syndrome. In our pa-
tient, the tumors were hormonally inactive; however, accord-
ing to literary data, hormonal activity of ovarian pathology in
Gorlin syndrome is possible. Ovarian masses, other than fi-
broma, i.e., fibrosarcoma and leiomyosarcoma, have also been
identified in patients with Gorlin syndrome [15] . 
In our patient, the expression of this Gorlin syndrome was
unusual, in that ovarian fibroids were the only manifestation
of the Gorlin syndrome, and the mutation was present in the
SUFU gene itself, not in the PTCH gene. PTCH has been identi-
fied on chromosome 9q22.3. PTCH , (patched) tumor suppres-
sor gene, modifies the hedgehog signaling pathway, a complex
pathway responsible for cell cycle regulation [13] . The SUFU
(Sufu negative regulator of hedgehog signaling) gene is located
on chromosome 10q24-q25. 
Our patient has SUFU c.246_249del, p.(Asn83Serfs ∗12). This
variant deletes 4 base pairs in exon 2 (of 12 total exons) and
generates a frameshift, leading to a premature stop codon at
position 12 in a new reading frame. It is predicted to lead to
loss of normal protein function, either through protein trun-
cation or nonsense-mediated mRNA decay. Loss of SUFU func-
tion is an established disease mechanism. SUFU c.246_249del,
p.(Asn83Serfs ∗12) is classified as likely pathogenic, based on
the established association between the gene and the pa-
tient’s phenotype, the variant’s absence in control popula-
tions, and variant type (frameshift). Disease caused by SUFU
variants is inherited in an autosomal dominant manner. Any
offspring of the patient are at 50% risk of inheriting the variant
and of being affected. SUFU -related disease may be caused by
a de novo variant. 
The SUFU gene encodes a component of the Sonic hedge-
hog (SHH)/Patched signaling pathway. Mutations in genes en-
coding this pathway are deleterious for normal development,
and are associated with cancer predisposing syndromes [16] . 
Taylor et al. [17] first identified germline variants in SUFU in
children with medulloblastoma. Subsequently, Brugiéres et al.





















































































[18] identified germline SUFU variants in 8 out of 131 patients
(6%) (6 truncating, 1 genomic deletion, 1 missense variant), all
under 3 years of age at the time of diagnosis. The reported
mutations have been predominantly truncating. 
SUFU related nevoid basal cell carcinoma syndrome
(NBCCS) is associated with a high risk for medulloblastoma of
up to 33% (3/9) and a high meningioma risk post radiation. Fa-
cial expressions are likely more subtle in individuals with an
SUFU pathogenic variant. Overall, clinical features are milder
in individuals with SUFU -related NBCCS, with less basal cell
carcinomas, and no jaw cysts reported [19] . 
When interpreting the radiological picture based on lit-
erary sources [ 7 ,20 ], a sclerosing multifocal ovarian tumor
was initially suspected. Both types of tumors—sclerosing stro-
mal tumor and thecoma-fibroma, belong to sex cord stro-
mal tumors and consist of fibrous stroma, but are not syn-
onymous [21] . Radiologically, fibroma is described to typically
show low signal intensity on T1-weighted MR images, and
marked hypointensity on T2-weighted images [3] ; the con-
trast medium enhancement of fibromas is heterogeneous and
mild-to moderate [ 22 ,23 ]. The sclerosing stromal tumor also
shows hypo- or isointensity, compared to normal muscles
in T1-weighted images, and intermediate to low signal in-
tensity in T2-weighted images; however, on postcontrast im-
ages, a typical early intensive peripheral enhancement with
centripetal progression and hypovascularized central area is
present [ 3 ,7 ]. In the case of our patient, the T1 post-contrast
image showed intensive contrast enhancement, along with
several hypovascularized regions, the largest of which was 5
cm in diameter. It is important to note that, for technical rea-
sons, a postcontrast dynamic series failed and the contrast-
enhanced T1 images were obtained 4 minutes after contrast
administration, showing intensive enhancement. This could
be a reason for misinterpretation, as the contrast enhance-
ment of fibromas in the late postcontrast series could also be
significantly intense. 
In the case of our patient, the tumor was pure fibroma by
histology and consisted only of fibrous tissue. Histologically, a
multifocal sclerosing tumor should also have pseudo-lobular
pattern in which cellular areas are separated by hypocellu-
lar areas consisting of an edematous collagen. Cellular ar-
eas should contain a dual population of cells comprising
of spindled fibroblastic cells and round to oval to polygo-
nal lipid containing cells (luteinized theca cells). Cellular ar-
eas can often reveal a thin-walled capillary network giving
hemangiopericytoma-like pattern. Calcification and ossifica-
tion, as well as the association with Gorlin syndrome, are most
common in fibroids [29] , however the association of multifo-
cal sclerosing stromal tumors with Gorlin syndrome is also
reported [3] . 
In the case of Gorlin syndrome, fibromas tend to reoc-
cur following tumorectomy, therefore bilateral adnexectomy
could be the definitive treatment for such a pathology. How-
ever, it would mean a long-term hormonal replacement ther-
apy, inability to produce offspring, as well as possibly in-
creased morbidity in women [24] . Therefore adnexectomy, es-
pecially bilateral, is rarely performed in children, and there is
very limited information about the follow-up. It is of the ut-
most importance to choose ovarian sparing techniques when-
ever possible. In the case that a bilateral adnexectomy is per-formed, cryopreservation of ovarian tissue could be consid-
ered. This could maintain the possibility of conception, whilst
at the same time reducing the need for repeated surgery
[ 5 ,25 ,26 ]. In our patient, one ovary was spared giving a chance
for fertility in the future. Surprisingly, she started menstruat-
ing soon after the surgery. There are several cases reported in
literature where women have had Gorlin syndrome with bilat-
eral fibromas, but have experienced normal menstrual cycles
and even preserved fertility. However, there are also a few re-
ports about women starting to have irregular menstruations
shortly before fibromas were diagnosed. The mechanism re-
garding the influence of fibromas on the menstrual cycle is
unclear, as they are generally not hormonally active [ 27 ,28 ].
Based on the large total volume of the ovarian formations and
the resumption of menstruation after their enucleation, it is
our opinion that the reason could be the mass effect of the
tumors on ovarian tissue. 
Conclusion 
• When ovarian fibromas are diagnosed in a pediatric pa-
tient, genetic surveillance should be performed, since the
diagnosis of Gorlin syndrome is suspected. 
• When interpreting radiological findings in pelvic forma-
tions, attention must be paid to the technical success of
the dynamic post-contrast series, as this is what can pro-
vide the most important information for a more accurate
interpretation of radiological findings. 
• Variants in SUFU gene can cause nevoid basal cell carci-
noma syndrome without the typical basal cell carcinomas
or jaw cysts. 
• When treating children and young women with adnexal
tumors, ovarian sparing techniques for fertility preserva-
tion are important aspects to consider. 
Patient consent 
The authors have obtained written consent by the patient,
stating that the patient agrees to the publication of this pa-
per including the pictures attached to this article. 
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